Back
Y-mAbs Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
YMAB
Sponsored
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.
Sell
39
YMAB
Y-mAbs Therapeutics
Last Price:
12.85
Seasonality Move:
18.11%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).Y-mAbs Therapeutics Price Quote
$12.85
-0.76 (-5.58%)
(Updated: May 9, 2024 at 6:55 PM ET)
Y-mAbs Therapeutics Key Stats
Sell
39
Y-mAbs Therapeutics (YMAB)
is a Sell
Day range:
$12.90 - $15.54
52-week range:
$4.60 - $20.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.82
P/B ratio:
7.45%
Volume:
1.6M
Avg. volume:
370.3K
1-year change:
101.03%
Market cap:
$752.4M
Revenue:
$84.8M
EPS:
$-0.49
How Much Does Y-mAbs Therapeutics Make?
-
How Much Are Y-mAbs Therapeutics's Sales Annually?
YMAB Revenues are $84.8M -
How Much Profit Does Y-mAbs Therapeutics's Make A Year?
YMAB net income is -$21.4M
Is Y-mAbs Therapeutics Growing As A Company?
-
What Is Y-mAbs Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.26% -
What Is Y-mAbs Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Y-mAbs Therapeutics Stock Price Performance
-
Did Y-mAbs Therapeutics Stock Go Up Last Month?
Y-mAbs Therapeutics share price went down by -5.81% last month -
Did YMAB's Share Price Rise Over The Last Year?
YMAB share price rose by 101.03% over the past 1 year
What Is Y-mAbs Therapeutics 52-Week High & Low?
-
What Is Y-mAbs Therapeutics’s 52-Week High Share Price?
Y-mAbs Therapeutics has traded as high as $20.90 over the past 52 weeks -
What Is Y-mAbs Therapeutics’s 52-Week Low Share Price?
Y-mAbs Therapeutics has traded as low as $4.60 over the past 52 weeks
Y-mAbs Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Y-mAbs Therapeutics?
-
How Much Debt Does Y-mAbs Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Y-mAbs Therapeutics Have?
Cash and short term investments quarterly total is $78.6M -
What Is Y-mAbs Therapeutics’s Book Value Per Share?
Book value per share is 2.31
Is Y-mAbs Therapeutics Cash Flow Positive?
-
What Is YMAB Cash Flow From Operations?
Cash flow from operations (TTM) is -$27.2M -
What Is Y-mAbs Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $100K -
What Is Y-mAbs Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Y-mAbs Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
YMAB return on invested capital is -20.49% -
What Is Y-mAbs Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -16.04% -
What Is YMAB Return On Equity?
ROE is a measure of profitability and is -20.49%
Y-mAbs Therapeutics Earnings Date & Stock Price
-
What Is Y-mAbs Therapeutics's Stock Price Today?
A single share of YMAB can be purchased today for 13.61 -
What Is Y-mAbs Therapeutics’s Stock Symbol?
Y-mAbs Therapeutics trades on the nasdaq under the ticker symbol: YMAB -
When Is Y-mAbs Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Y-mAbs Therapeutics is scheduled on August 9, 2024 -
When Is YMAB's next ex-dividend date?
Y-mAbs Therapeutics's next ex-dividend date is May 10, 2024 -
How To Buy Y-mAbs Therapeutics Stock?
You can buy Y-mAbs Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Y-mAbs Therapeutics Competitors
-
Who Are Y-mAbs Therapeutics's Competitors?
Below is a list of companies who compete with Y-mAbs Therapeutics or are related in some way:
Y-mAbs Therapeutics Dividend Yield
Data Unavailable
Y-mAbs Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 89.13% |
Revenue: | -25.71% | 11.5% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 1 |
Price Target: | 21.67 |
Upside from Last Price: | 59.2% |